Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Communiqués de presse de la société NOVARTIS AG
05/26Timber Pharmaceuticals Lists To NYSE; Adds $20 Million And A Novel Pipeline T..
AQ
05/2610 YEARS OF BIOSIMILARS : Lessons And Trends
AQ
05/26NOVARTIS : study reveals that migraine support in the workspace can significantl..
PU
05/20NOVARTIS : AveXis receives EC approval and activates 'Day One' access program fo..
AQ
05/14NOVARTIS : Sandoz Glatopa demonstrates trend towards lower relapse rates and cos..
AQ
05/07INCYTE : Novartis announces FDA approval of MET inhibitor Tabrecta for metastati..
AQ
05/07BAUSCH HEALTH : and Alfasigma Announce Resolution of XIFAXAN Intellectual Proper..
AQ
05/06NOVARTIS : CJEU Confirms Strict Interpretation Of Article 3(a) For SPCs
AQ
05/04Sosei Heptares notes that Enerzair Breezhaler has been recommended for approv..
AQ
04/30NOVARTIS : Cosentyx gains fourth indication in EU with first-in-class approval i..
AQ
04/29ALCON : Novartis maintains strong operational performance in Q1, confirms FY 202..
AQ
04/28NOVARTIS : 1Q Earnings Snapshot
AQ
04/28NOVARTIS : Q1 2020 Results Presentation
PU
04/23NOVARTIS : announces data showing Jakavi more effective than best available ther..
AQ
04/23NOVARTIS : Kymriah receives FDA Regenerative Medicine Advanced Therapy designati..
AQ
04/21NOVARTIS : NCLAT Sets Aside CCI Order İmposing Penalty On Eli Lilly For Gun..
AQ
04/21UBISOFT ENTERTAINMENT : Novartis acquires Amblyotech, pursuing novel digital the..
AQ
03/31NOVARTIS : Sandoz - Novartis donation, Consignment of 30 million hydroxychloroqu..
AQ
03/31NOVARTIS : donates 20,000 doses of hydroxychloroquine for COVID-19 PEP clinical ..
AQ
03/30NOVARTIS : AveXis receives positive CHMP opinion for Zolgensma, the only gene th..
AQ
03/30NOVARTIS : Cosentyx gains positive CHMP opinion for new indication in the axial ..
AQ
03/30NOVARTIS : HHS accepts donations of medicine to Strategic National Stockpile as ..
AQ
03/26NOVARTIS : ROSEN, A HIGHLY RANKED FIRM, Continues to Investigate Securities Clai..
BU
03/25NOVARTIS : AveXis - Zolgensma data shows rapid, significant, clinically meaningf..
AQ
03/24NOVARTIS : Sandoz acquires US distribution rights to two key hospital injectable..
AQ
03/23NOVARTIS : commits to donate up to 130 million doses of hydroxychloroquine to su..
AQ
03/20NOVARTIS : receives approval from Japanese Ministry of Health, Labour and Welfar..
AQ
03/19NCLAT Affirms That The De Minimis Exemption Should Have Always Applied To The..
AQ
03/10INVESTIGATION ALERT : The Schall Law Firm Announces it is Investigating Claims A..
BU
03/02NOVARTIS : Drug maker Sandoz Inc. to pay $195M fine in antitrust case
AQ
03/02NOVARTIS : shareholders approve all resolutions proposed by the Board of Directo..
AQ
02/26NOVARTIS : Gov't panel OKs world's most expensive drug used in gene therapy
AQ
02/25NOVARTIS INDIA : launches Biome India, a digital innovation hub in Hyderabad fir..
AQ
02/25NOVARTIS : and DNDi to collaborate on the development of a new oral drug to trea..
PU
02/24NOVARTIS : Genmab - U.S. FDA Filing Acceptance and Priority Review for sBLA Subm..
AQ
02/17Carrols Restaurant Group Names Markus Hartmann as General Counsel
AQ
02/04NOVARTIS : Boston Pharmaceuticals Appoints Dr. Craig T. Basson, MD, PhD, as Chie..
AQ
02/04NOVARTIS : Two persons die in separate accidents on railway tracks
AQ
02/03NOVARTIS : Cosentyx builds on its axSpA leadership with US label update for dosi..
AQ
02/03NOVARTIS : Sandoz completes acquisition of Aspen's Japanese operations, strength..
AQ
01/31NOVARTIS : Cosentyx® builds on its axSpA leadership with US label update for dos..
PU
01/29NOVARTIS : Media presentation
PU
01/29NOVARTIS : 4Q Earnings Snapshot
AQ
01/29NOVARTIS : investors presentation
PU
01/21NOVARTIS : announces EU approval of Mayzent for adult patients with secondary pr..
AQ
01/07Ironwood and Allergan Announce Settlement Resolving LINZESS Patent Litigation
AQ
01/03ADAMAS PHARMACEUTICALS : Announces Settlement of Patent Litigation with Sandoz
AQ
2019NOVARTIS : receives positive CHMP opinion for Beovu for the treatment of wet AMD
AQ
2019NOVARTIS : global survey uncovers profound and often under-reported effects on s..
AQ
2019NOVARTIS : Kymriah demonstrates consistent efficacy and safety outcomes in US pa..
AQ
2019NOVARTIS : breadth of data at 2019 ASH demonstrates commitment to reimagining me..
AQ
2019NOVARTIS : ROSEN, A GLOBAL LAW FIRM, Continues to Investigate Securities Claims ..
BU
2019MEDICINES : Novartis to acquire The Medicines Company for USD 9.7 bn, adding inc..
AQ
2019NOVARTIS : to acquire The Medicines Company for USD 9.7 bn, adding inclisiran, a..
PU
2019NOVARTIS : launches Innovation Prize for Assistive Tech to encourage new technol..
PU
2019NOVARTIS : PARAGON-HF analyses suggest Entresto benefit beyond HFrEF
AQ
2019NOVARTIS : New Novartis medicine Adakveo approved by FDA to reduce frequency of ..
AQ
2019NOVARTIS : receives positive CHMP opinion for Mayzent for the treatment of adult..
AQ
2019NOVARTIS : announces new strategy to provide innovative medicines to more patien..
AQ
2019NOVARTIS : Aspen Global Incorporated - Divestment of Aspens Japanese operations
AQ
2019NOVARTIS : Sandoz announces agreement to acquire Aspen's Japanese operations and..
AQ
2019NOVARTIS : data show tropifexor significantly improves several key biomarkers of..
AQ
2019ASPEN PHARMACARE : Novartis agrees sale for Aspen's Japanese brand
AQ
2019NOVARTIS : Sandoz lowers Glatopa price in US to offer people with MS high-qualit..
AQ
2019NOVARTIS : Cosentyx shows encouraging results versus Humira from first-of-its-ki..
AQ
2019MorphoSys AG - MOR106 Clinical Development in Atopic Dermatitis Stopped for f..
AQ
2019NOVARTIS : delivered another strong quarter with double digit sales growth and c..
AQ
2019NOVARTIS : 3Q Earnings Snapshot
AQ
2019NOVARTIS : 2019 Q3 results - presentation (PDF 1.3 MB)
PU
2019NOVARTIS : 2019 Q3 results - Interim financial report
PU
2019INCYTE : Novartis announces that Jakavi meets primary endpoint in Phase III stud..
AQ
2019INCYTE : Announces that the REACH2 Pivotal Trial of Ruxolitinib Meets Primary En..
AQ
2019NOVARTIS : announces that Jakavi® (ruxolitinib) meets primary endpoint in Phase ..
PU
2019NOVARTIS : Sandoz and Pear Therapeutics announce Pear will solely commercialize ..
AQ
2019NOVARTIS : data show Cosentyx treatment results in rapid and sustained resolutio..
AQ
1  2  3  4  5  6  7  8  9  10Next